greeksoup/ stock research
Stock research / United States / GSK / Year to 31 December 2025

GSK plc (GSK) annual results, year to 31 December 2025: revenue GBP 32,667 million, from the 20-F

GSK plc files a 20-F with the SEC once a year, in pounds sterling. In the year to 31 December 2025 it reported revenue of GBP 32,667 million ($43.1 billion at the year's average rate), up 4.1% on the year before. Its profit attributable to shareholders was GBP 5,716 million, up 122.0%, and diluted earnings per share GBP 1.39.

Revenue
GBP 32,667 million
+4.1% on the year
FY2018FY2025
Operating margin
24.3%
12.8% a year earlier
FY2018FY2025
Net income
GBP 5,716 million
+122.0% on the year
FY2018FY2025
Diluted EPS
GBP 1.39
+123.2% on the year
FY2018FY2025

this yearthe year beforeIn pounds sterling as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2024Dec 2025
Revenue31,37632,667
Cost of sales9,0489,017
Gross profit22,32823,650
Research and development6,4017,525
Selling, general and administrative11,0159,088
Operating profit4,0217,932
Finance costs669701
Profit before tax3,4777,401
Income tax5261,112
Profit for the year2,9516,289
Profit attributable to shareholders2,5755,716
Filing20-F20-F
GBP million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2024Dec 2025
Diluted EPS0.621.39
Basic EPS0.631.41
Filing20-F20-F

GBP per ordinary share, as filed.

Cash flow

Year toDec 2024Dec 2025
Cash from operations6,5547,741
Purchase of property, plant and equipment1,3991,348
Free cash flow5,1556,393
Cash from investing-1,229-4,233
Cash from financing-4,726-3,685
Depreciation and amortisation2,5512,314
Buybacks0.01,377
Dividends paid2,4442,564
Filing20-F20-F

GBP million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2024Dec 2025
Funded by
Equity attributable to shareholders13,67116,377
Non-controlling interests-585-421
Borrowings, as filed16,98617,720
Lease liabilities1,102830
Other liabilities28,28926,612
Total equity and liabilities59,46361,118
Owned
Property, plant and equipment9,2279,322
Goodwill6,9827,018
Other intangible assets15,51516,748
Cash and cash equivalents3,8703,397
Trade and other receivables6,8367,471
Inventories5,6695,924
Other assets11,36411,238
Total assets59,46361,118
Filing20-F20-F

GBP million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2024Dec 2025
Gross margin71.2%72.4%
Operating margin12.8%24.3%
Net margin8.2%17.5%
Free cash flow margin16.4%19.6%
Return on year-end equity18.8%34.9%
Effective tax rate15.1%15.0%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2025, filed 6 March 2026: the filing. The figures are in pounds sterling as filed.